Source: United States & Canada – South China Morning PostSoftBank Group Corp’s Vision Fund 2 led a US$75 million funding round for Embark Veterinary Inc, a genetics start-up that seeks to increase dog lifespans.The transaction values the US-based company at US$700 million, Embark CEO Ryan Boyko said in an interview.“We give pet owners and breeders tools to create the best future for their dogs and want to be able to expand our audience,” Boyko said, noting that Embark plans to use the proceeds for hiring and product development. “The topic of…Read More